LB-102

• Description:

  LB-102 is an orally active inhibitor of dopamine D2, D3, and 5-HT7 receptors, which can be used in research on schizophrenia and other psychiatric disorders[1].

• UNSPSC:

  12352211

• Target:

  5-HT Receptor; Dopamine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/lb-102.html

• Smiles:

  CCN1CCCC1CNC(C2=CC(S(=O)(CC)=O)=C(C=C2OC)NC)=O

• Molecular Formula:

  C18H29N3O4S

• Molecular Weight:

  383.51

• References & Citations:

  [1]Wong D F, et al. PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement[J]. Neuropsychopharmacology, 2024: 1-6.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 2

• Isoform:

  5-HT7 Receptor

• CAS Number:

  [2227154-23-4]